|
Feb 21
|
Charles River (CRL) Gains From CRADL Amid Soft Market Scenario
|
|
Feb 21
|
Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
|
|
Feb 20
|
Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells
|
|
Jan 18
|
Charles River's (CRL) New Launch to Boost Gene Therapy Programs
|
|
Jan 16
|
Ten Big Losers To Start The Year. Tesla Isn't The Worst.
|
|
Jan 16
|
Charles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing
|
|
Jan 12
|
10 Narrow Moat Stocks Hedge Funds Are Buying
|
|
Dec 27
|
What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing?
|
|
Dec 19
|
Charles River's (CRL) Memphis Site Achieves Crucial Approval
|
|
Dec 18
|
Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration
|
|
Dec 13
|
Charles River (CRL) Expands 3D In Vitro Services Via New Deal
|
|
Dec 12
|
Charles River Finalizes Agreement with CELLphenomics, Expanding 3D In Vitro Services for Cancer Therapy Drug Screening
|
|
Dec 11
|
Does Charles River Laboratories International (NYSE:CRL) Deserve A Spot On Your Watchlist?
|
|
Dec 8
|
Charles River (CRL) Up 19.7% Since Last Earnings Report: Can It Continue?
|
|
Dec 2
|
Insider Sell: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL)
|
|
Nov 29
|
Charles River (CRL) Backs the Quest to Cure SPG56 via New Deal
|
|
Nov 28
|
Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
|
|
Nov 27
|
Charles River Laboratories to Present at Evercore ISI Investor Conference
|
|
Nov 17
|
Charles River (CRL) Widens CliniPrime GMP Suite With New Launch
|
|
Nov 17
|
Charles River Laboratories International Insiders Added US$1.91m Of Stock To Their Holdings
|